Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fumiki Oh
Short-Term Efficacy (At 12 Weeks) and Long-Term Safety (Up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia ― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Related publications
A Randomized Controlled, Double-Blind Evaluation of the Short-Term(8 Weeks) Efficacy and Safety of Godex in Korean Chronic Hepatitis Patients
Journal of Korean Society for Clinical Pharmacology and Therapeutics
Adalimumab for Nail Psoriasis: Efficacy and Safety Over 52 Weeks From a Phase‐3, Randomized, Placebo‐Controlled Trial
Journal of the European Academy of Dermatology and Venereology
Dermatology
Infectious Diseases
Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-To-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Randomized, Double Blind, Placebo-Controlled Study on Long-Term Prophylaxis With Echinacea Purpurea
Reviews on Clinical Pharmacology and Drug Therapy
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Adalimumab for Nail Psoriasis: Efficacy and Safety From the First 26 weeks of a Phase 3, Randomized, Placebo-Controlled Trial
Journal of the American Academy of Dermatology
Dermatology
Long-Term Efficacy and Safety of Brodalumab in the Treatment of Psoriasis: 120-Week Results From the Randomized, Double-Blind, Placebo- And Active Comparator–controlled Phase 3 AMAGINE-2 Trial
Journal of the American Academy of Dermatology
Dermatology
Omega-3 Fatty Acid Treatment of Women With Borderline Personality Disorder: A Double-Blind, Placebo-Controlled Pilot Study
American Journal of Psychiatry
Psychiatry
Mental Health
Efficacy and Safety of Long-Term Fluoxetine Versus Lithium Monotherapy of Bipolar II Disorder: A Randomized, Double-Blind, Placebo-Substitution Study
American Journal of Psychiatry
Psychiatry
Mental Health
